Fiera Capital Corp Halozyme Therapeutics, Inc. Transaction History

Fiera Capital Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$31.82 - $40.75 $19 Million - $24.3 Million	-595,626 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$38.47 - $46.42 $383,007 - $462,157	-9,956 Reduced 1.64%	595,626 $24.2 Million
Q2 2021 Aug 11, 2021	SELL	$38.84 - $51.31 $643,617 - $850,258	-16,571 Reduced 2.66%	605,582 $16.2 Million
Q1 2021 May 11, 2021	BUY	$39.51 - $51.45 $24.6 Million - $32 Million	622,153 New	622,153 $25.9 Million

538

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.75B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Fiera Capital Corp with notifications on news.